Shimadzu Opens Branch Office in Denmark
Shimadzu, has opened a new branch office in Copenhagen, Denmark.
Analytical instrumentation specialist, Shimadzu, has revealed that its new branch office, located in Copenhagen, Denmark, is up and running, providing local support to Danish industries.
According to an Oct 14, 2020 press release, the branch office, which began operating in September 2020, is located in Ballerup in Greater Copenhagen. At 355 sqm in size, the Danish office houses eight Shimadzu employees who cover sales, services, and administration duties for the local region.
“We have chosen this location for our branch office as it connects in two directions,” said Morten Thorslund, sales and service manager of the Shimadzu Denmark Branch Office, in the press release. “[The] Greater Copenhagen region, as the country’s economic and scientific heartland, [is] well-known for its chemical and pharmaceutical industries as well as the metal-processing sectors.”
The Danish office includes administration space, in addition to a demonstration lab—where customers can see the Shimadzu systems in operation and test them prior to purchase—and seminar rooms—where experts will present on the latest applications and solutions.
Source: Shimadzu
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
